Farmacja Polska (Oct 2023)

New Medicine Service as support for medication adherence by chronically ill patients

  • Magdalena Waszyk-Nowaczyk,
  • Justyna Dymek,
  • Mariola Drozd,
  • Olga Sierpniowska,
  • Agnieszka Stankiewicz,
  • Artur Jędra,
  • Magdalena Jasińska-Stroschein

DOI
https://doi.org/10.32383/farmpol/172894
Journal volume & issue
Vol. 79, no. 5
pp. 281 – 288

Abstract

Read online

Effective management of the treatment for chronically ill patients is a multifactorial process. The crucial is an accurate diagnosis, appropriate and well-designed pharmacotherapy, as well as patient medication adherence. Adherence is defined as the extent to which patients are able to follow the general practitioner's recommendations for the prescribed treatments. Patients’ reasons for deviating from the treatment plan are diverse and may be intentional or unintentional. They may be non-adherent during different stages of their treatment. Some patients may decide not to fill physician prescriptions and not start their treatment at all. Patients may use more or less than the prescribed medication or use their treatments at the wrong time. They may also discontinue therapy prematurely. The common reasons for medication non-adherence may include lack of symptoms, improvement in health, in patients’ subjective opinion, fear of potential side effects, long-term conditions, multimorbidity, and polypharmacy. Poor knowledge about medicines can also lead to severe consequences such as non-adherence. Several interventions may contribute to improved adherence. The current legislation in pharmaceutical care enables registered pharmacists to intervene successfully when a medicine is prescribed, increase effective medicine taking for the treatment of a long-term condition, and optimize the therapy; they also may offer the patient, opportunistic advice on healthy living or public health topics in line with the promotion of healthy lifestyles. One of the proposed pharmaceutical care services for Polish patients – the New Medicine Service, was introduced in England in 2011 as support for subjects starting a newly initiated medication for long-term treatment. The article presents the assumptions and goals for this pharmaceutical consultation in polish system of health care, discusses the interview schedule and forms, and describes the service's beneficial contribution to better medication adherence by chronically ill patients.

Keywords